News Guest User 10/6/26 Guest User 10/6/26 Scope’s CRISPR Molecular Diagnostics CE marked for antifungal resistance Read More Guest User 6/16/25 Guest User 6/16/25 Scope Biosciences secures follow-on investment to scale up its CRISPR diagnostics platform Read More Guest User 3/7/24 Guest User 3/7/24 Scope Biosciences secures €2.5 Million EIC-Transition grant to revolutionize Point-of-Care diagnostics with the CRISPR-Cas based scopeDx platform Read More Guest User 10/23/23 Guest User 10/23/23 Scope Biosciences raises 500K investment from SHIFT and Oost NL Read More Guest User 4/5/22 Guest User 4/5/22 Laboratory at Campus Wageningen Read More Older Posts
Guest User 10/6/26 Guest User 10/6/26 Scope’s CRISPR Molecular Diagnostics CE marked for antifungal resistance Read More
Guest User 6/16/25 Guest User 6/16/25 Scope Biosciences secures follow-on investment to scale up its CRISPR diagnostics platform Read More
Guest User 3/7/24 Guest User 3/7/24 Scope Biosciences secures €2.5 Million EIC-Transition grant to revolutionize Point-of-Care diagnostics with the CRISPR-Cas based scopeDx platform Read More
Guest User 10/23/23 Guest User 10/23/23 Scope Biosciences raises 500K investment from SHIFT and Oost NL Read More
